Financials
- Market Capitalization 364.22 M
- Employee 81
- Founded 1999
- CEO N/A
- Website www.agenusbio.com
- Headquarter Delaware, United States
- FIGI BBG000C8SWQ9
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
1.01
売上高対価格比率
0.81
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3151 | IRD Opus Genetics, Inc. - Common Stock | 4.32 USD | +12.79% | +9.64% | +16.13% | +16.13% | 359.41 M USD | ||
| 3152 | LYEL Lyell Immunopharma, Inc. - Common Stock | 14.66 USD | +0.89% | -0.95% | +12.34% | -39.40% | 359.25 M USD | ||
| 3181 | IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.51 USD | +5.46% | +0.80% | +14.61% | +43.43% | 350.24 M USD | ||
| 3197 | PALI Palisade Bio, Inc. - Common Stock | 1.98 USD | +1.02% | -6.60% | +4.21% | +16.47% | 345.06 M USD |